2015
DOI: 10.1111/hae.12629
|View full text |Cite
|
Sign up to set email alerts
|

Selective angiographic embolization for recurrent elbow and knee haemarthroses in haemophilia: a retrospective case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 9 publications
(19 reference statements)
1
8
0
Order By: Relevance
“…Vascular structures on PD assumed large confluent, pulsatile shapes that were described previously and appear unique to hemophilia in that they are absent in normal joints and osteoarthritis and less pronounced in rheumatoid arthritis . Of note, distorted synovial vascular structures resembling pseudoaneurysms in bleeding hemophilic joints were described before in case series during angiography and embolization, providing additional evidence that not only neoangiogenesis but also vascular remodeling is an important feature of progressive hemophilic arthropathy .…”
Section: Discussionsupporting
confidence: 52%
“…Vascular structures on PD assumed large confluent, pulsatile shapes that were described previously and appear unique to hemophilia in that they are absent in normal joints and osteoarthritis and less pronounced in rheumatoid arthritis . Of note, distorted synovial vascular structures resembling pseudoaneurysms in bleeding hemophilic joints were described before in case series during angiography and embolization, providing additional evidence that not only neoangiogenesis but also vascular remodeling is an important feature of progressive hemophilic arthropathy .…”
Section: Discussionsupporting
confidence: 52%
“…Successful control of recurrent bleeding into target joints and improvement of chronic synovitis has been reported using selective angiographic embolization. There are no large studies but the approach may be useful in selected patients.…”
Section: Management Of Chronic Synovitis and Target Jointsmentioning
confidence: 99%
“…Furthermore, no clinical trials addressing the efficacy of synthetic or biological DMARDs in controlling synovitis have yet been conducted partly because of the lack of sensitive outcome parameters, disease heterogeneity in small populations, and the long follow‐up required. To reduce the burden of inflammation that predisposes to recurrent bleeding by refuelling angiogenesis and synovial hyperplasia, patients with refractory disease may benefit from joint embolisation, 93 or methods of synovial ablation such as chemical synoviorthesis with rifampicin or tetracyclines and radioisotopic synovectomy. 94 , 95 …”
Section: Challenges In the Treatment Of Hemophilic Arthropathymentioning
confidence: 99%